A Prospective, Interventional Clinical Study to evaluate the efficacy and safety of Jolly Tulsi 51 drops for Boosting Immune system and Detoxification in healthy subjects.

Jolly Health Care0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Healthy Male and female subjects who has taken at least 3 course any type antibiotics in the past 3 months.
•2.Pregnant women will be included in the study.
•3. Mentally, physically and legally eligible to give informed consent.
•4. Male and female BMI between 18.0 â?? 30.0 kg/m2
•5. Subjects is willing and able to comply with all trial requirements
•6. Subjects who have not participated in a similar investigation in the past three months
•7. Normal thyroid function

•1. Subjects with history or presence of cancer
•2. Subjects with history of a psychiatric disorder and or drug or alcohol abuse or dependency;
•3. Subjects having a known intolerance to gluten or lactose
•4. Subjects having a known allergy to any ingredient in the investigational product
•5. Subjects with Medical history of gastrointestinal bleeding or gastric or duodenal ulcer.
•6. Subjects having any other medical condition which, in the opinion of the investigator, could interfere with participation in the study.

发起方

Jolly Health Care